Hilltelligence markHilltelligence
Bills/H.Res. 928119th Congress

Affirming support for most-favored-Nation drug pricing for United States patients.

House: Referred
Cosponsors
1
Introduced
2025-12-04
Last action
2025-12-04

Referred to the House Committee on Energy and Commerce.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the House Committee on Energy and Commerce.

  2. House

    Submitted in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Sign in to view Hilltelligence’s potential-cosponsor analysis.